Detalhe da pesquisa
1.
Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders.
Pharmacol Rev
; 75(4): 554-674, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36918261
2.
Age-dependent effects of the ß3 adrenoceptor agonist CL316,243 on human and rat detrusor muscle strips.
Pflugers Arch
; 476(2): 243-256, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37993748
3.
Efficacy and Safety of High-Dose Vitamin D Supplementation vs Solifenacin or Standard Urotherapy for Overactive Bladder Dry in Children: A Randomized Clinical Trial.
J Urol
; 211(1): 26-36, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37871329
4.
Detrusor relaxing agents for neurogenic detrusor overactivity: a systematic review, meta-analysis and network meta-analysis.
BJU Int
; 133(1): 25-33, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37500569
5.
Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial.
World J Urol
; 42(1): 113, 2024 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38431689
6.
Efficacy and safety of the implantable, magnetic resonance imaging-compatible StimRouter neuromodulation system in the treatment of refractory lower urinary tract symptoms in multiple sclerosis patients.
Eur J Neurol
; 31(2): e16146, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37975785
7.
Unraveling the interplay between dyskinesia and overactive bladder symptoms in Parkinson's disease: a comprehensive cohort study based on the long-term follow-up database of Parkinson's disease.
BMC Neurol
; 24(1): 94, 2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38468238
8.
Patient and physician decision-making dynamics in overactive bladder care: A mixed methods study.
Neurourol Urodyn
; 43(3): 565-573, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38334205
9.
Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin-A injection for overactive bladder: A multi-institutional collaboration from the SUFU Research Network (SURN).
Neurourol Urodyn
; 43(2): 407-414, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38032120
10.
How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.
Neurourol Urodyn
; 43(4): 811-817, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38451038
11.
Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review.
Neurourol Urodyn
; 43(3): 553-564, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38225733
12.
The association of lower urinary tract symptoms with schizophrenia and its treatments: A narrative review.
Neurourol Urodyn
; 43(1): 114-125, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37916430
13.
Safety and efficacy of an α1 -blocker plus mirabegron compared with an α1 -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis.
Neurourol Urodyn
; 43(3): 604-619, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38291827
14.
The Response of the Urinary Microbiome to Botox.
Int Urogynecol J
; 35(1): 237-251, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38165444
15.
Effects of Transcutaneous Tibial Nerve Stimulation in Women Refractory to and Never Used Pharmacological Agents for Idiopathic Overactive Bladder.
Int Urogynecol J
; 35(3): 571-578, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38206337
16.
Antibiotic prophylaxis for onabotulinum toxin A injections: systematic review and meta-analysis.
Int Urogynecol J
; 35(1): 19-29, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37938397
17.
The prevalence of probable overactive bladder and associated risk factors among medical students in Jordan: a cross-sectional study.
BMC Urol
; 24(1): 7, 2024 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38172746
18.
Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder.
BMC Urol
; 24(1): 97, 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38664686
19.
Mirabegron Add-On Tamsulosin for Men with Overactive Bladder Symptoms: A Pooled Analysis of Four Randomized Controlled Trials.
Urol Int
; 108(2): 118-127, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38185112
20.
Development and characterization of 3D printed ethylene vinyl acetate (EVA) as drug delivery device for the treatment of overactive bladder.
Drug Dev Ind Pharm
; 50(4): 285-296, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38486377